Beam Therapeutics Inc.
BEAM
•Stock Analysis$25.98
+0.00 (+0.00%)• Live
Beam Therapeutics Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Beam Therapeutics Inc.
Key Financial Metrics
for Beam Therapeutics Inc.
P/E Ratio
-4.06
Revenue Growth
-83.18%
EPS Growth
-166.28%
Market Cap
$1.80B
Dividend Yield
0.00%
Debt/Equity
0.14
ROIC
-32.18%
FCF Yield
-20.06%
View additional metrics
Valuation
P/B Ratio1.40
EV/Sales22.48
Financial Health
Current Ratio8.81
Return on Assets-26.41%
Analyst Recommendations
for Beam Therapeutics Inc.
27 analysts
Consensus: Buy
About
for Beam Therapeutics Inc.
Company Details
for Beam Therapeutics Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
John M. Evans
Employees
393
Market Cap
2.63B
Exchange
NASDAQ Global Select
IPO Date
February 6, 2020
Website
www.beamtx.comCIK
0001745999
ISIN
US07373V1052
CUSIP
07373V105
Country
US
Balance Sheet
for Beam Therapeutics Inc.
Cash Flow Statement
for Beam Therapeutics Inc.
Income Statement
for Beam Therapeutics Inc.
News
No news available at the moment.